Clinical trial
Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help…
NCT00338585 · ARCA Biopharma, Inc., Industry · Terminated
Key facts
| NCT number | NCT00338585 |
|---|---|
| Title | Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery |
| Official title | Phase 3, Multicenter, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Acute Peripheral Arterial Occlusion (NAPA-3) |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | alfimeprase |
| Enrollment | 300 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: